Taipei Exchange - Delayed Quote TWD

3D Global Biotech Inc. (6808.TWO)

60.10
-1.30
(-2.12%)
As of 10:46:19 AM GMT+8. Market Open.
Loading Chart for 6808.TWO
  • Previous Close 61.40
  • Open 61.40
  • Bid 60.10 x --
  • Ask 60.50 x --
  • Day's Range 60.00 - 61.40
  • 52 Week Range 33.70 - 73.50
  • Volume 186,213
  • Avg. Volume 472,180
  • Market Cap (intraday) 4.678B
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) 46.23
  • EPS (TTM) 1.30
  • Earnings Date --
  • Forward Dividend & Yield 0.53 (0.86%)
  • Ex-Dividend Date Jul 7, 2025
  • 1y Target Est --

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orthopedic, tooth and jaw, and skull reconstruction products, and scalp care products. It serves medical centers, research institutions, and companies and distributors to establish an interdisciplinary alliance encompassing industry, government, academia, research, and medicine. The company was founded in 2014 and is based in New Taipei City, China.

www.3dglobalbiotech.com.tw

43

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6808.TWO

View More

Performance Overview: 6808.TWO

Trailing total returns as of 6/16/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6808.TWO
9.35%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
4.72%

1-Year Return

6808.TWO
51.39%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.48%

3-Year Return

6808.TWO
96.73%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
38.57%

5-Year Return

6808.TWO
0.17%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
90.65%

Compare To: 6808.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6808.TWO

View More

Valuation Measures

Annual
As of 6/13/2025
  • Market Cap

    4.78B

  • Enterprise Value

    4.16B

  • Trailing P/E

    47.23

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    16.36

  • Price/Book (mrq)

    5.28

  • Enterprise Value/Revenue

    15.66

  • Enterprise Value/EBITDA

    35.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    34.51%

  • Return on Assets (ttm)

    8.12%

  • Return on Equity (ttm)

    15.31%

  • Revenue (ttm)

    265.69M

  • Net Income Avi to Common (ttm)

    91.7M

  • Diluted EPS (ttm)

    1.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    703.86M

  • Total Debt/Equity (mrq)

    9.37%

  • Levered Free Cash Flow (ttm)

    -24.67M

Research Analysis: 6808.TWO

View More

Company Insights: 6808.TWO

Research Reports: 6808.TWO

View More

People Also Watch